Related Experiment Video
Updated: Jul 19, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases
1Department of Pathology, University Health Network and Toronto Medical Laboratories, and University Hospital Hamburg Eppendorf, Ontario, Canada.
Abstract:
CEACAM1, also known as biliary glycoprotein (BGP), CD66a, pp120 and C-CAM1, is a member of the CEA immunoglobulin superfamily. CEACAM1 is a putative tumor suppressor based on diminished expression in some solid neoplasms such as colorectal carcinoma. However, CEACAM1 is overexpressed in some tumors such as non-small cell lung cancer. To clarify the mechanism of action of this cell adhesion molecule, we studied thyroid carcinoma that has a spectrum of morphologies and variable behavior allowing separation of proliferation from invasion and metastasis. CEACAM1 is expressed in thyroid carcinoma cell lines derived from tumors that exhibit aggressive behavior. Introduction of CEACAM1 into endogenously deficient WRO cells resulted in reduced cell cycle progression associated with p21 upregulation and diminished Rb phosphorylation. Forced CEACAM1 expression enhanced cell-matrix adhesion and migration and promoted tumor invasiveness. Conversely, small interfering RNA (siRNA)-mediated downregulation of CEACAM1 expression in MRO cells accelerated cell cycle progression and significantly enhanced tumor size in xenografted mice. CEACAM1 is not appreciably expressed in normal thyroid tissue or benign thyroid tumors. In a human thyroid tissue array, CEACAM1 reactivity was associated with metastatic spread but not with increased tumor size. These findings identify CEACAM1 as a unique mediator that restricts tumor growth whereas increasing metastatic potential. Our data highlight a complex repertoire of actions providing a putative mechanism underlying the spectrum of biologic behaviors associated with thyroid cancer.
Insights
The cell adhesion molecule CEACAM1 (carcinoembryonic antigen cell adhesion molecule 1) restricts thyroid tumor growth but enhances metastasis. Its expression in thyroid carcinoma is linked to aggressive behavior and spread.
Area of Science:
- Molecular biology
- Cancer research
- Cell adhesion molecules
Background:
- CEACAM1 (carcinoembryonic antigen cell adhesion molecule 1), also known as BGP, CD66a, pp120, and C-CAM1, is part of the CEA immunoglobulin superfamily.
- CEACAM1's role in cancer is complex; it's considered a tumor suppressor in some cancers (e.g., colorectal carcinoma) but overexpressed in others (e.g., non-small cell lung cancer).
- Thyroid carcinoma presents a spectrum of behaviors, making it a suitable model to study CEACAM1's dual role in proliferation, invasion, and metastasis.
Purpose of the Study:
- To elucidate the mechanism of action of the cell adhesion molecule CEACAM1 in thyroid carcinoma.
- To investigate the relationship between CEACAM1 expression and tumor growth, invasion, and metastasis in thyroid cancer.
- To clarify the contrasting roles of CEACAM1 in tumor progression.
Main Methods:
- Studied CEACAM1 expression in thyroid carcinoma cell lines with varying aggressive behaviors.
- Manipulated CEACAM1 expression using gene introduction and small interfering RNA (siRNA)-mediated downregulation in thyroid cancer cells.
- Assessed cell cycle progression, Rb phosphorylation, cell-matrix adhesion, migration, invasiveness, and tumor growth in xenograft models.
- Analyzed CEACAM1 expression in a human thyroid tissue array, correlating it with clinical parameters like tumor size and metastasis.
Main Results:
- CEACAM1 is expressed in aggressive thyroid carcinoma cell lines.
- Overexpression of CEACAM1 in deficient cells reduced cell cycle progression, upregulated p21, and decreased Rb phosphorylation, while enhancing adhesion, migration, and invasiveness.
- Downregulation of CEACAM1 accelerated cell cycle progression and increased tumor size in vivo.
- CEACAM1 is absent in normal thyroid tissue and benign tumors but its reactivity correlates with metastatic spread in human thyroid cancer tissues.
Conclusions:
- CEACAM1 acts as a unique mediator in thyroid cancer, paradoxically restricting tumor growth while promoting metastatic potential.
- The findings suggest CEACAM1 plays a critical role in the diverse biological behaviors observed in thyroid cancer.
- CEACAM1's complex actions provide a potential mechanism for understanding the spectrum of thyroid cancer progression.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:35Cancer Cell Migration through Invadopodia
02:38Mitogens and the Cell Cycle
01:31Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:17The Tumor Microenvironment